CGP-37157
CAS: 75450-34-9
Ref. 3D-ADA45034
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Name:
CGP-37157
Synonyms:
- 4,1-Benzothiazepin-2(3H)-one, 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-
Description:
CGP-37157 is a mitochondria-targeting compound that inhibits mitochondrial functions. It has been shown to inhibit calcium uptake and release into the cytosol, as well as inhibit ATP production. CGP-37157 also blocks the mitochondrial permeability transition pore, preventing cell death. This drug is currently being investigated for its use in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
324.22 g/mol
Formula:
C15H11Cl2NOS
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
